Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration

被引:35
|
作者
Imfeld-Isenegger, Tamara Leila [1 ]
Soares, Ines Branco [2 ]
Makovec, Urska Nabergoj [3 ]
Horvat, Nejc [3 ]
Kos, Mitja [3 ]
van Mil, Foppe [4 ]
Costa, Filipa A. [2 ]
Hersberger, Kurt E. [1 ]
机构
[1] Univ Basel, Pharmaceut Care Res Grp, Basel, Switzerland
[2] IUEM, CiiEM, Campus Univ, P-2829511 Monte De Caparica, Caparica, Portugal
[3] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
[4] Von Mil Consultancy, Margrietlaan 1, NL-9471 CT Zuidlaren, Netherlands
来源
关键词
Medication review; Community pharmacy services; Primary health care; Service implementation; Remuneration; Europe; DRUG-RELATED PROBLEMS; FOLLOW-UP SERVICE; PHARMACEUTICAL CARE; THERAPY MANAGEMENT; POLYPHARMACY; TERMINOLOGY; ELIGIBILITY;
D O I
10.1016/j.sapharm.2019.11.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Pharmaceutical Care Network Europe (PCNE) proposed a definition and classification system (type 1, 2a, 2b, 3) for medication review in 2016. However, to date, a description of the implementation and remuneration of such procedures across Europe is lacking. Objective: The aim of this study was to describe the medication review procedures and the level of implementation and remuneration in community pharmacies across Europe. Methods: An online survey was developed to characterize medication review procedures (PCNE classification), level of implementation (considering regional or national) and remuneration by a third party. This survey was sent to a purposive sample of three individuals per country, with a working background in community pharmacy, pharmacy practice research, or health policy to ensure reliable data. Data triangulation was used and consensus sought between the responses. Results: Data were received from 34 out of 44 targeted European countries (November 2016-October 2017) [response rate = 77%]. Overall, 55.9% of the countries provided at least one type of medication review as an implemented service or project. Type 1 medication review (based on the medication history) was provided in 13 countries, type 2a (medication history + patient interview) in 14, type 2b (medication history + clinical data) in two, and type 3 medication review (medication history + patient interview + clinical data) in four countries. Ten of the mentioned services or projects were remunerated by a third-party. Conclusion: Substantial heterogeneity was observed across Europe in various aspects, including the procedures, implementation level and remuneration obtained. Type 1 and 2a medication review services seem to be more feasible to implement in the community pharmacy than type 2b and 3. A large number of medication review projects were ongoing in community pharmacies, which suggests that new medication review services could become implemented in the coming years.
引用
收藏
页码:1057 / 1066
页数:10
相关论文
共 50 条
  • [31] Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model
    Timothy F. Chen
    Drugs & Aging, 2016, 33 : 199 - 204
  • [32] Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model
    Chen, Timothy F.
    DRUGS & AGING, 2016, 33 (03) : 199 - 204
  • [33] Clinical pharmacist-led medication review to evaluate inappropriate prescriptions in pediatric patients
    Isik, M. N.
    Dalgic, N.
    Okuyan, B.
    Yildirmak, Z. Y.
    Kose, G.
    Urganci, N.
    Kaya, A.
    Akinci, N.
    Sancar, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 344 - 344
  • [34] IMPLEMENTATION OF A PHARMACIST-LED ALBUMIN STEWARDSHIP PROGRAM
    Rouse, Ginger
    Knopp, Aaron
    West, Ashley
    McGill, Bryan
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 475 - 475
  • [35] Implementation of a pharmacist-led transitional care clinic
    Layman, Sara N.
    Elliott, Whitney V.
    Regen, Sloan M.
    Keough, Leigh Anne
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (12) : 966 - 971
  • [36] Evaluation of a Pharmacist-Led Implementation of Standardized Medication Administration Times for Inpatients Receiving Hemodialysis
    Blunier, Abbie L.
    Cheatham, Megan R.
    Deodhar, Karishma S.
    Geik, Christopher A.
    Walroth, Todd A.
    Whitten, Jessica A.
    Davis, Christie M.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 1027 - 1033
  • [37] Pharmacist-led medication review:: comment on Holland et al. 2008
    Silcock, Jonathan
    Petty, Duncan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (04) : 575 - 575
  • [38] The effects of a pharmacist-led medication review in a nursing home A randomized controlled trial
    Liou, Wen-Shyong
    Huang, Shih-Ming
    Lee, Wei-Hsin
    Chang, Yen-Lin
    Wu, Ming-Fen
    MEDICINE, 2021, 100 (48)
  • [39] Pharmacist-led medication review in a residential in-reach service leads to deprescribing
    Hui, Jia Hao
    Parikh, Seema
    O'Donnell, Lisa Kouladjian
    Mcinerney, Brigid
    Dillon, Louise
    Poojary, Suma
    Crabtree, Amelia
    AUSTRALASIAN JOURNAL ON AGEING, 2023, 42 (04) : 675 - 682
  • [40] Pharmacist-led medication review in an acute admissions unit: a systematic procedure description
    Graabaek, Trine
    Bonnerup, Dorthe Krogsgaard
    Kjeldsen, Lene Juel
    Rossing, Charlotte
    Pottegard, Anton
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2015, 22 (04) : 202 - 206